Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM4KS4Nonsteroidal anti-inflammatory and antirheumatic agents
XM7W23Butylpyrazolidines

XM12M5 category

Oxyphenbutazone

Also indexed as

HydroxyphenylbutazoneOxyphenbutazoneTandearil

Nearby in Butylpyrazolidines

XM8HN0Phenylbutazone
XM8P27Mofebutazone
XM8X86Clofezone
XM4H41Kebuzone

PreviousXM8P27 — Mofebutazone NextXM8X86 — Clofezone

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
XM4G94Antidepressants
XM98Y0Cannabinoids or hallucinogens
14 more
XM4KS4Nonsteroidal anti-inflammatory and antirheumatic agents
Specific antirheumatic agents
Acetylsalicylic acid and other salicylates
Pyrazolone derivatives
Paracetamol (acetaminophen) and 4-aminophenol derivatives
Other nonopioid analgesics and antipyretics, not elsewhere classified
XM6HK1Antimigraine drugs
XM7W23Butylpyrazolidines
XM74U4Acetic acid derivatives and related substances
XM0UL8Oxicams
XM2S54Propionic acid derivatives
XM9DC7Fenamates
XM16D6Coxibs
XM7AM9Glafenine
XM3WB0Floctafenine
XM8WS4Nabumetone
17 more
XM8HN0Phenylbutazone
XM8P27Mofebutazone
XM12M5Oxyphenbutazone
XM8X86Clofezone
XM4H41Kebuzone

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact